Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CRISPR
CRISPR
Tango Adds $60M in CRISPR Hunt for Synthetically Lethal Cancer Drugs
Xconomy
Thu, 04/9/20 - 10:28 am
Tango Therapeutics
CRISPR
cancer
drug development
CRISPR Therapeutics braces for 'severe impact' from COVID-19 crisis
Fierce Biotech
Wed, 04/1/20 - 09:54 am
CRISPR
CRISPR Therapeutics
COVID-19
clinical trials
CRISPR pioneer Doudna opens lab to run Covid-19 tests
Stat
Mon, 03/30/20 - 10:35 am
Jennifer Doudna
CRISPR
laboratories
diagnostics
COVID-19
In its first use inside the human body, CRISPR genome editing tested as blindness therapy
Stat
Wed, 03/4/20 - 10:50 am
gene therapy
blindness
CRISPR
genome editing
Sickle Cell Disease: After Years Of Neglect Some Promise For Sufferers
Forbes
Mon, 02/17/20 - 10:26 am
sickle cell disease
Oxbryta
Adakveo
Endari
olinciguat
CRISPR
Here's Why CRISPR Stocks Fell in January
Motley Fool
Wed, 02/5/20 - 10:07 am
Intellia Therapeutics
CRISPR Therapeutics
Editas Medicine
CRISPR
Mammoth Biosciences Raises $45 Million For Crispr Diagnostics—And Its Tech Is Already Being Used Against Coronavirus
Forbes
Thu, 01/30/20 - 09:44 pm
Mammoth Biosciences
IPOs
CRISPR
Overview: CRISPR Technology Headed to Clinical Trials
BioSpace
Wed, 01/8/20 - 10:33 am
CRISPR
Editas Medicine
clinical trials
Allergan
LCA10
Four Major Biopharma Scandals in 2019
BioSpace
Thu, 01/2/20 - 10:44 am
scandal
Novartis
Zolgensma
data manipulation
China
CRISPR
IP theft
Purdue Pharma
Sackler family
oxycontin
This Start-up Might Be the Next Gene Editing IPO
Motley Fool
Thu, 12/19/19 - 12:50 pm
gene editing
Beam Therapeutics
IPOs
CRISPR
Hopkins team invents non-viral system for getting gene therapy into cells
Fierce Biotech
Fri, 12/6/19 - 09:29 pm
Johns Hopkins
gene therapy
CRISPR
Celgene Gave This Tech Back to Editas Medicine, but It Could Prove Valuable
Motley Fool
Thu, 12/5/19 - 11:32 pm
Celgene
Editas Medicine
Juno Therapeutics
CRISPR
gene editing
More CRISPR Stock Catalysts Ahead
Motley Fool
Mon, 11/25/19 - 09:38 am
gene editing
CRISPR
Editas Medicine
Intellia Therapeutics
CRISPR Therapeutics
Biotech Stock Pops On Promising First In-Human CRISPR Gene-Editing Drug
Investors Business Daily
Wed, 11/20/19 - 09:53 am
CRISPR Therapeutics
gene editing
CRISPR
beta thalassemia
sickle cell disease
Editas and Celgene sub Juno are tackling hottest immunotherapy cells
Endpoints
Tue, 11/12/19 - 08:07 pm
Editas Medicine
Celgene
Juno Therapeutics
CRISPR
gene editing
immunotherapy
A Look at America’s First CRISPR Clinical Trial
Xtalks
Mon, 11/11/19 - 10:59 am
CRISPR
gene editing
clinical trials
How Prime Solves CRISPR’s Big Problem
BioSpace
Thu, 11/7/19 - 11:07 pm
CRISPR
CRISPR Prime
gene therapy
First use of CRISPR against cancer in patients clears early safety hurdles
Stat
Wed, 11/6/19 - 10:36 am
gene editing
CRISPR
patient safety
cancer
Oooooh, That’s Scary! Welcome to the Dark Side of Biopharma
BioSpace
Thu, 10/31/19 - 10:37 am
CRISPR
drug pricing
Novartis
Zolgensma
bioterrorism
Elizabeth Holmes
Martin Shkreli
A deal-hungry Vertex ushers in three more gene editing programs as it closes out harbinger CRISPR deal
Endpoints
Mon, 10/28/19 - 10:54 am
Vertex Pharmaceuticals
CRISPR
gene editing
CTX001
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
next ›
last »